Day & Ennis, LLC recently filed their 13F report for the fourth quarter of 2022, which ended on 2022-12-31.
The 13F report details which stocks were in a guru’s equity portfolio at the end of the quarter, though investors should note that these filings are limited in scope, containing only a snapshot of long positions in U.S.-listed stocks and American depository receipts as of the quarter’s end. They are not required to include international holdings, short positions or other types of investments. Still, even this limited filing can provide valuable information.
Building 400 Macon, GA 31210
As of the latest 13F report, the guru’s equity portfolio contained 119 stocks valued at a total of $258.00Mil. The top holdings were
According to GuruFocus data, these were Day & Ennis, LLC’s top five trades of the quarter.
iShares iBonds Dec 2023 Term Treasury ETF
The guru established a new position worth 445,858 shares in NAS:IBTD, giving the stock a 4.26% weight in the equity portfolio. Shares traded for an average price of $24.58 during the quarter.
On 01/27/2023, iShares iBonds Dec 2023 Term Treasury ETF traded for a price of $24.75 per share and a market cap of $2.44Bil. The stock has returned -0.66% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
iShares iBonds Dec 2024 Term Treasury ETF
The guru established a new position worth 453,201 shares in NAS:IBTE, giving the stock a 4.18% weight in the equity portfolio. Shares traded for an average price of $23.74 during the quarter.
On 01/27/2023, iShares iBonds Dec 2024 Term Treasury ETF traded for a price of $23.9482 per share and a market cap of $1.83Bil. The stock has returned -3.08% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
iShares iBonds Dec 2023 Term Corporate ETF
Day & Ennis, LLC reduced their investment in ARCA:IBDO by 208,514 shares. The trade had a 2.17% impact on the equity portfolio. During the quarter, the stock traded for an average price of $24.88.
On 01/27/2023, iShares iBonds Dec 2023 Term Corporate ETF traded for a price of $25.13 per share and a market cap of $2.24Bil. The stock has returned 0.20% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
iShares iBonds Dec 2022 Term Corporate ETF
The guru sold out of their 196,671-share investment in ARCA:IBDN. Previously, the stock had a 2.05% weight in the equity portfolio. Shares traded for an average price of $25.03 during the quarter.
On 01/27/2023, iShares iBonds Dec 2022 Term Corporate ETF traded for a price of $25.055 per share and a market cap of $1.20Bil. The stock has returned -0.22% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
iShares iBonds Dec 2024 Term Corporate ETF
Day & Ennis, LLC reduced their investment in ARCA:IBDP by 154,209 shares. The trade had a 1.56% impact on the equity portfolio. During the quarter, the stock traded for an average price of $24.32.
On 01/27/2023, iShares iBonds Dec 2024 Term Corporate ETF traded for a price of $24.6078 per share and a market cap of $2.31Bil. The stock has returned -2.35% over the past year.
There is insufficient data to calculate the stock’s financial strength and profitability ratings.
Please note, the numbers and facts quoted are as of the writing of this article and may not factor in the latest trading data or company announcements.
When GuruFocus covers insider information, we only track open market or the private purchase and sale of common stock with the transaction code of P or S. Therefore, all the transactions mentioned in this article are only the ones with transaction code of P or S.
Want to provide feedback on this article? Have questions or concerns? Get in touch with us here, or email us at [email protected]!
This article is general in nature and does not represent the opinions of GuruFocus or any of its affiliates. This article is not intended to be financial advice, nor does it constitute investment advice or recommendations. It was written without regard to your individual situation or financial goals. We aim to bring you fundamental, data-driven analysis, The information on this site is in no way guaranteed for completeness, accuracy or in any other way.
